Compare with ALKYL AMINES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CRESTCHEM vs ALKYL AMINES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CRESTCHEM ALKYL AMINES CRESTCHEM/
ALKYL AMINES
 
P/E (TTM) x 17.9 60.2 29.8% View Chart
P/BV x 12.9 24.5 52.6% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 CRESTCHEM   ALKYL AMINES
EQUITY SHARE DATA
    CRESTCHEM
Mar-20
ALKYL AMINES
Mar-21
CRESTCHEM/
ALKYL AMINES
5-Yr Chart
Click to enlarge
High Rs162,396 0.7%   
Low Rs11444 2.4%   
Sales per share (Unadj.) Rs20.7608.7 3.4%  
Earnings per share (Unadj.) Rs1.5144.7 1.0%  
Cash flow per share (Unadj.) Rs1.5158.9 1.0%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Avg Dividend yield %00.7 0.0%  
Book value per share (Unadj.) Rs3.1386.9 0.8%  
Shares outstanding (eoy) m3.0020.41 14.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.62.3 27.1%   
Avg P/E ratio x8.89.8 90.1%  
P/CF ratio (eoy) x8.48.9 94.6%  
Price / Book Value ratio x4.33.7 116.4%  
Dividend payout %06.9 0.0%   
Avg Mkt Cap Rs m3928,981 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m1588 0.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6212,424 0.5%  
Other income Rs m070 0.4%   
Total revenues Rs m6212,494 0.5%   
Gross profit Rs m64,291 0.1%  
Depreciation Rs m0291 0.1%   
Interest Rs m063 0.1%   
Profit before tax Rs m64,007 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m11,054 0.1%   
Profit after tax Rs m42,953 0.2%  
Gross profit margin %9.234.5 26.6%  
Effective tax rate %22.126.3 83.9%   
Net profit margin %7.223.8 30.1%  
BALANCE SHEET DATA
Current assets Rs m95,279 0.2%   
Current liabilities Rs m22,818 0.1%   
Net working cap to sales %11.319.8 57.1%  
Current ratio x4.61.9 247.5%  
Inventory Days Days777 9.6%  
Debtors Days Days2670 0.4%  
Net fixed assets Rs m28,287 0.0%   
Share capital Rs m30102 29.4%   
"Free" reserves Rs m-217,794 -0.3%   
Net worth Rs m97,896 0.1%   
Long term debt Rs m0216 0.0%   
Total assets Rs m1113,566 0.1%  
Interest coverage x115.064.3 178.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x5.50.9 602.7%   
Return on assets %39.922.2 179.5%  
Return on equity %48.337.4 129.3%  
Return on capital %62.650.2 124.7%  
Exports to sales %016.7 0.0%   
Imports to sales %010.1 0.0%   
Exports (fob) Rs mNA2,076 0.0%   
Imports (cif) Rs mNA1,251 0.0%   
Fx inflow Rs m02,076 0.0%   
Fx outflow Rs m01,282 0.0%   
Net fx Rs m0794 0.0%   
CASH FLOW
From Operations Rs m33,640 0.1%  
From Investments Rs m-3-2,127 0.2%  
From Financial Activity Rs mNA-865 0.0%  
Net Cashflow Rs m0649 -0.0%  

Share Holding

Indian Promoters % 30.2 71.9 42.0%  
Foreign collaborators % 1.4 0.1 1,183.3%  
Indian inst/Mut Fund % 0.1 3.4 3.8%  
FIIs % 0.0 2.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 68.4 28.0 244.6%  
Shareholders   11,254 173,629 6.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CRESTCHEM With:   CHEMBOND CHEMICALS  AARTI INDUSTRIES  SREE RAYAL  DCW.  ANUPAM RASAYAN  



Today's Market

Sensex Ends 383 Points Higher; Metal and Realty Stocks Rally(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

ALKYL AMINES 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of ALKYL AMINES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ALKYL AMINES. Also includes updates on the valuation of ALKYL AMINES.

ALKYL AMINES Announces Quarterly Results (1QFY22); Net Profit Up 48.8% (Quarterly Result Update)

Aug 5, 2021 | Updated on Aug 5, 2021

For the quarter ended June 2021, ALKYL AMINES has posted a net profit of Rs 785 m (up 48.8% YoY). Sales on the other hand came in at Rs 4 bn (up 59.8% YoY). Read on for a complete analysis of ALKYL AMINES's quarterly results.

ALKYL AMINES Announces Quarterly Results (4QFY21); Net Profit Up 88.2% (Quarterly Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

For the quarter ended March 2021, ALKYL AMINES has posted a net profit of Rs 926 m (up 88.2% YoY). Sales on the other hand came in at Rs 4 bn (up 62.8% YoY). Read on for a complete analysis of ALKYL AMINES's quarterly results.

More Views on News

Most Popular

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You...(Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Tata Group Stocks are on Fire: Which one Should You Buy?(Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally(Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

India's Big PSU Selloff: Watch Out for these Top Stocks(Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CRESTCHEM SHARE PRICE


Oct 26, 2021 (Close)

TRACK CRESTCHEM

  • Track your investment in CRESTCHEM with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE CRESTCHEM WITH

MARKET STATS